Long-term safety and efficacy of N8-GP in previously treated adults and adolescents with hemophilia A: Final results from pathfinder2.

CONCLUSION: Data from the completed pathfinder2 trial, one of the largest and longest-running clinical trials to investigate treatment of severe hemophilia A, demonstrate the efficacy and safety of N8-GP in previously treated adolescent and adult patients.
PMID: 32544297 [PubMed - as supplied by publisher]

Source: Thrombosis and Haemostasis - June 15, 2020 Category: Hematology Authors: Giangrande P, Abdul Karim F, Nemes L, You CW, Landorph A, Geybels MS, Curry N Tags: J Thromb Haemost Source Type: research